Application 091008
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 100MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 300MG | No | No |
| 003 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091008-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A091008-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | dd7adad2-e2f5-4b43-90a4-522bce0be5b3 | 2026-11-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Havix Group Inc d-b-a Aavis Pharmaceuticals | ad6c10e6-fc39-4ca2-942f-a56c4457e144 | 2026-11-06 | GABAPENTIN GABAPENTIN | |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4615aaa7-73d4-4473-8f26-e7a982f8a166 | 2026-11-05 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-11-04 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c33c4d83-cc13-4104-9e24-d4cd40b17b70 | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 5769d849-4f27-4701-97ec-7e3ca07339d7 | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1006139-7dfc-4d87-a5a9-aeb380c32d24 | 2026-10-30 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | e2d9bd8c-3bb9-4945-8e61-7d2703d9008c | 2026-10-30 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fb726cb0-d422-48dd-a8ed-adbde812b005 | 2026-10-29 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7f830664-2fa3-4d73-a154-775fbb8fd65d | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 6a0a75ac-e121-477b-a9d1-d11f588afc9d | 2026-10-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 78088f6a-06a3-422f-b336-4a57a24adc16 | 2026-10-27 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 5ab9c18b-9568-4dcb-90b0-252aef8f8dc2 | 2026-10-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-10-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-10-19 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 5de61c1f-8e6f-b70a-e063-6294a90a1c21 | 2026-10-15 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | b4c7388a-19d9-4e3a-83c9-4943fb855be4 | 2026-10-14 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | e877a425-2b7f-4e43-a1f9-24019cbf9685 | 2026-10-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Granules Pharmaceuticals Inc. | e847bcfa-f3de-404a-8a57-d8a414691e6a | 2026-10-08 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |